Centiva Capital »

Arcus Biosciences Incorporated shares owned by Centiva Capital

Quarter-by-quarter ownership of Arcus Biosciences Incorporated (RCUS) shares owned by Centiva Capital from 13F filings

Historical chart of Centiva Capital investment in Arcus Biosciences Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Arcus Biosciences Incorporated held by Centiva Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcus Biosciences Incorporated by Centiva Capital

Quarter filed Position value Share count Share price at filing
2023-06-30 $711k 35k 20.31

More positions owned by Centiva Capital

Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation (NVDA)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Tesla Motors (TSLA)
Regeneron Pharmaceuticals Call Option (REGN)
Pdd Holdings Sponsored Ads (PDD)
Microsoft Corporation (MSFT)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Amazon (AMZN)
Kraneshares Trust Csi Chi Internet Put Option (KWEB)
Apple Call Option (AAPL)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)

View all positions for Centiva Capital

Top funds holding Arcus Biosciences Incorporated

Gilead Sciences
BlackRock
Vanguard Group
Point72 Asset Management
Woodline Partners
Suvretta Capital Management
State Street Corporation
Siren
FMR
Balyasny Asset Management
Geode Capital Management
Dimensional Fund Advisors
Barclays
Bnp Paribas Investment Partners
Wellington Management Company

View all funds holding Arcus Biosciences Incorporated